End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
442.8 MXN | +21.44% |
|
-.--% | +21.44% |
08:38am | Markets bullish in wake of bullish US trend | AN |
Jun. 17 | Stock exchanges in green except London; focus on EU policy | AN |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Its low valuation, with P/E ratio at 9.24 and 8.51 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The company has a low valuation given the cash flows generated by its activity.
- The company is one of the best yield companies with high dividend expectations.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
Ratings chart - Surperformance
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+21.44% | 37.84B | - | ||
+7.53% | 49.98B | B | ||
+5.93% | 49.34B | B+ | ||
+20.80% | 45.52B | B+ | ||
+11.35% | 41.12B | B+ | ||
+19.81% | 33.88B | B | ||
-3.39% | 27.68B | B | ||
-10.03% | 26.61B | B- | ||
+28.74% | 26.04B | A | ||
-21.10% | 24.24B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- G Stock
- GASI N Stock
- Ratings Generali